These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 21085091

  • 1. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 Nov 19; 59(45):1488-91. PubMed ID: 21085091
    [Abstract] [Full Text] [Related]

  • 2. Syringe exchange programs--United States, 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Nov 09; 56(44):1164-7. PubMed ID: 17989646
    [Abstract] [Full Text] [Related]

  • 3. Doing harm reduction better: syringe exchange in the United States.
    Des Jarlais DC, McKnight C, Goldblatt C, Purchase D.
    Addiction; 2009 Sep 09; 104(9):1441-6. PubMed ID: 19215605
    [Abstract] [Full Text] [Related]

  • 4. Update: syringe exchange programs--United States, 2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Jul 15; 54(27):673-6. PubMed ID: 16015218
    [Abstract] [Full Text] [Related]

  • 5. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
    Int J Drug Policy; 2007 Oct 15; 18(5):417-25. PubMed ID: 17854731
    [Abstract] [Full Text] [Related]

  • 6. Update: syringe exchange programs--United States, 1998.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 May 18; 50(19):384-7. PubMed ID: 11465907
    [Abstract] [Full Text] [Related]

  • 7. Update: syringe-exchange programs--United States, 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Jun 20; 46(24):565-8. PubMed ID: 9221326
    [Abstract] [Full Text] [Related]

  • 8. The role of needle exchange programs in HIV prevention.
    Vlahov D, Junge B.
    Public Health Rep; 1998 Jun 20; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [Abstract] [Full Text] [Related]

  • 9. Update: syringe exchange programs--United States, 1997.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1998 Aug 14; 47(31):652-5. PubMed ID: 9716397
    [Abstract] [Full Text] [Related]

  • 10. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
    Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN.
    Drug Alcohol Depend; 2006 Feb 01; 81(2):167-78. PubMed ID: 16043308
    [Abstract] [Full Text] [Related]

  • 11. Strategies to improve access to sterile syringes for injection drug users.
    Rich JD, Wolf FA, Macalino G.
    AIDS Read; 2002 Dec 01; 12(12):527-35. PubMed ID: 12518719
    [Abstract] [Full Text] [Related]

  • 12. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
    Heimer R.
    Public Health Rep; 1998 Jun 01; 113 Suppl 1(Suppl 1):67-74. PubMed ID: 9722811
    [Abstract] [Full Text] [Related]

  • 13. Public funding of US syringe exchange programs.
    Des Jarlais DC, McKnight C, Milliken J.
    J Urban Health; 2004 Mar 01; 81(1):118-21. PubMed ID: 15047790
    [Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN.
    J Subst Abuse Treat; 2007 Jun 01; 32(4):423-9. PubMed ID: 17481466
    [Abstract] [Full Text] [Related]

  • 15. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R, Diffusion of Benefit through Syringe Exchange Study Team.
    Addiction; 2004 Sep 01; 99(9):1136-46. PubMed ID: 15317634
    [Abstract] [Full Text] [Related]

  • 16. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C, Cox J, De P, Tremblay C, Roy E, Allard R, Stephenson R, Graves L.
    Int J Drug Policy; 2007 May 01; 18(3):204-12. PubMed ID: 17689367
    [Abstract] [Full Text] [Related]

  • 17. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
    Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M.
    Bull World Health Organ; 1999 May 01; 77(10):789-800. PubMed ID: 10593026
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.
    Addiction; 2010 May 01; 105(5):844-59. PubMed ID: 20219055
    [Abstract] [Full Text] [Related]

  • 19. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
    Tempalski B, Cooper HL, Friedman SR, Des Jarlais DC, Brady J, Gostnell K.
    Int J Drug Policy; 2008 Apr 01; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
    [Abstract] [Full Text] [Related]

  • 20. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA, Lee MA, Callahan DB, Gonzales P, Murray PJ, Margolis HS.
    Am J Prev Med; 2005 Jul 01; 29(1):27-33. PubMed ID: 15958248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.